Vasili Berdoukas OAM, M.B. B.S., FRACP	Comparing iron chelators for the treatment of thalassaemia – What are the differences? Learning Objectives Review the classes of iron chelators available in terms of their physiochemical characteristics and safety and efficacy Discuss the most recent clinical data evaluating the effect of different iron chelators on surrogate markers of iron chelation efficacy Learn about the impact on cardioprotection and survival for available iron chelators Please Login to access the archives
Renzo Galanello MD	Combination therapy in thalassaemia – A review of treatment strategies to maximize patient outcomes Learning Objectives Understand the rationale for selecting combination therapy as a treatment option for thalassaemia major patients Learn how different iron chelators can be used in combination therapy Gain insight into combination therapy treatment strategies Review the most recent clinical data for optimizing the use of iron chelators in combination Please Login to access the archives
Caterina Borgna-Pignatti MD	Survival in Thalassaemia - Does the choice of iron chelator make a difference? Review the most recent survival data for patients with thalassaemia major Gain insight into the improvements seen in patient survival through iron chelation Learn how different iron chelators impact patient survival Review country specific examples on the changes in survival Please Login to access the archives
Dudley Pennell MD FRCP FACC FESC	How can MRI be used to optimize the management of thalassaemia? In this webcast, new information regarding cardiovascular magnetic resonance (CMR) and it’s use in thalassaemia management will be discussed. Please Login to access the archives